This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on april 22, 2019. upon further investigation of the reported event, the following information is new and/or changed: date received by manufacturer, indication that this is a follow-up report, follow-up due to additional information, identification of evaluation codes 4114, 3259, 4307.Method code: 4114 - device not returned.Results code: 3259 - improper physical structure.Conclusions code: 4307 - cause traced to component failure.The affected sample was not returned for evaluation.A retention sample from the same production/lot number combination was not tested as the lot number was provided.An engineering investigation and capa have been initiated to determined a definitive root cause.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|